ArticleVaccines2022

Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study.

Seiichiro Katagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.